Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB vs PALIVIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB vs PALIVIZUMAB: Safety Overview

Metric NIRSEVIMAB PALIVIZUMAB
Total FAERS Reports 247 11,419
Deaths Reported 5 1,248
Death Rate 2.0% 10.9%
Hospitalizations 149 6,461
Average Patient Age 0.3 yrs 0.8 yrs
% Female Patients 42.3% 42.2%
Manufacturer Sanofi Pasteur Inc. Swedish Orphan Biovitrum AB (publ)
Route INTRAMUSCULAR INTRAMUSCULAR
Marketing Status N/A Prescription